Latest AI and machine learning research in parkinson's disease for healthcare professionals.
BACKGROUND AND OBJECTIVE: Motor diagnosis, monitoring and management of Parkinson's disease (PD) foc...
OBJECTIVE: To develop and validate a deep neural network (DNN) model for diagnosing Parkinson's Dise...
Machine learning approaches including deep learning models have shown promising performance in the a...
Both brain functional connectivity (FC) and structural connectivity (SC) provide distinct neural mec...
Parkinson's Disease (PD) is a growing burden with varied clinical manifestations and responses to Su...
Current pharmacotherapy for neurodegenerative diseases is limited to providing symptomatic relief, i...
Neurological disorders are a major global health concern that have a substantial impact on death rat...
Accurate prediction of Parkinson's disease tremor (PDT) is crucial for developing assistive technolo...
OBJECTIVE: Functional imaging using the dopamine transporter (DAT) as a biomarker has proven effecti...
BACKGROUND: Postural instability greatly reduces quality of life in people with Parkinson's disease ...
Timely identification of Parkinson's disease and schizophrenia is crucial for the effective manageme...
BackgroundClinical assessments of motor symptoms rely on observations and subjective judgments again...
BACKGROUND AND OBJECTIVE: The worldwide estimates reveal two-fold increase in incidence of Parkinson...
The human brain is a highly complex neurological system that has been the subject of continuous expl...
Diagnosing Parkinson's disease (PD) via speech is crucial for its non-invasive and convenient data c...
INTRODUCTION: The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is a wel...
Neural networks (NNs) possess the capability to learn complex data relationships, recognize inherent...
Parkinson Disease (PD) is a complex neurological disorder attributed by loss of neurons generating d...
Parkinson's disease (PD), as the second most prevalent neurodegenerative disorder worldwide, impacts...
BACKGROUND: Parkinson's disease (PD), the second most common neurodegenerative disease in the world,...
BACKGROUND AND OBJECTIVES: Patients with synucleinopathies such as multiple system atrophy (MSA) and...